EGFR and diffuse intrinsic pontine glioma: Fleischhack et al. assessed the safety and efficacy of intravenous nimotuzumab, an anti-EGFR humanized monoclonal antibody, combined with external beam radiotherapy (EBT) among treatment-naïve patients with DIPG diagnosed in the last 3 months.